Skip to main content
. 2022 Dec 20;12(1):25. doi: 10.3390/jcm12010025

Figure 3.

Figure 3

Median values of biochemical disease control parameters at enrolment in patients resistant (R-SRL) and in those responsive to somatostatin receptor ligands (S-SRL) (* p < 0.0001, ** p = 0.0002).